Calamos Advisors LLC - ISIS PHARMACEUTICALS INC DEL ownership

ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of ISIS PHARMACEUTICALS INC DEL
ValueSharesWeighting
Q2 2020$1,934,000
-29.2%
1,750,000
-35.0%
0.01%
-33.3%
Q1 2020$2,732,000
-19.2%
2,693,000
-8.7%
0.02%
+23.5%
Q4 2019$3,383,000
-93.8%
2,950,000
-93.9%
0.02%
-94.3%
Q3 2019$54,824,000
-3.8%
48,113,000
+0.1%
0.30%
-5.4%
Q2 2019$56,972,000
+2.1%
48,074,000
+16.7%
0.32%
-9.2%
Q1 2019$55,801,000
+85.2%
41,197,000
+47.1%
0.35%
+74.9%
Q4 2018$30,136,000
+20.6%
28,007,000
+18.7%
0.20%
+45.3%
Q3 2018$24,993,000
+7.9%
23,600,0000.0%0.14%
-3.5%
Q2 2018$23,171,000
-0.7%
23,600,0000.0%0.14%
-6.6%
Q1 2018$23,343,000
-6.7%
23,600,0000.0%0.15%
+18.8%
Q4 2017$25,028,000
+34.7%
23,600,000
+34.9%
0.13%
-11.1%
Q3 2017$18,584,000
-0.3%
17,500,0000.0%0.14%
+4.3%
Q2 2017$18,648,000
+10.4%
17,500,0000.0%0.14%
+3.8%
Q1 2017$16,898,000
-5.6%
17,500,0000.0%0.13%
-6.3%
Q4 2016$17,896,000
+9.4%
17,500,0000.0%0.14%
+21.4%
Q3 2016$16,353,000
+32.2%
17,500,0000.0%0.12%
+34.5%
Q2 2016$12,373,000
-39.7%
17,500,000
-22.1%
0.09%
-36.0%
Q1 2016$20,529,000
-19.1%
22,479,000
-0.1%
0.14%
-15.5%
Q4 2015$25,390,00022,507,0000.16%
Other shareholders
ISIS PHARMACEUTICALS INC DEL shareholders Q2 2018
NameSharesValueWeighting ↓
Sonora Investment Management, LLC 16,935,000$17,946,697,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 45,700,000$48,504,0002.18%
TENOR CAPITAL MANAGEMENT Co., L.P. 20,000,000$21,312,0001.66%
LINDEN ADVISORS LP 34,494,000$36,562,0001.30%
WOLVERINE ASSET MANAGEMENT LLC 96,239,000$101,731,0001.13%
MACKAY SHIELDS LLC 24,155,000$25,567,0000.95%
Verition Fund Management LLC 10,200,000$10,799,0000.87%
Jabre Capital Partners S.A. 4,000,000$4,243,0000.82%
ADVENT CAPITAL MANAGEMENT /DE/ 38,030,000$40,330,0000.76%
AQR Arbitrage LLC 44,600,000$47,220,0000.51%
View complete list of ISIS PHARMACEUTICALS INC DEL shareholders